[Antiviral effect of abikoviromycin].
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000906:Antibodies / Q000032:analysis; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity; D002646:Chikungunya virus / Q000472:pathogenicity; D003864:Depression, Chemical; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology; D029822:Enterovirus B, Human / Q000276:immunology / Q000472:pathogenicity; D009522:Newcastle disease virus / Q000472:pathogenicity; D009975:Orthomyxoviridae / Q000276:immunology / Q000472:pathogenicity; D013302:Streptomyces / Q000378:metabolism; D014616:Vaccinia virus / Q000472:pathogenicity; D014762:Viral Interference / Q000187:drug effects*; D014774:Virulence / Q000187:drug effects; D014780:Viruses / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000906:Antibodies; D000998:Antiviral Agents
Antivirusnoe deĭstvie abikoviromitsina.